Diabetes

Filter

mazdutide

Mazdutide Outperforms Dulaglutide in Type 2 Diabetes Trial

January 2026

Mazdutide, a dual glucagon and GLP-1 agonist, delivers greater HbA1c and weight reductions than dulaglutide in people with type 2 diabetes.

Comparative Study Questions Cardiovascular Safety of Glipizide

Discover how new research found that glipizide carries higher cardiovascular risk than DPP4 inhibitors in Type 2 diabetes treatment.

Global Study Finds No Overall Link Between Gestational Diabetes and Breast Cancer

Although the link between Type 2 diabetes and increased breast cancer risk is well established, the relationship between GDM and breast cancer has remained unclear.

Traditional Chinese Medicine Boosts ED Drug Efficacy in Patients with Diabetes

Learn how TCM plus PDE5 inhibitors boosts erectile function in diabetes patients, with no extra side effects reported.

SGLT-2 Inhibitors May Lower Risk of Serious Liver Events in Cirrhosis

Discover how SGLT-2 inhibitors are linked with reduced risk of serious liver events in cirrhosis patients.

Dapagliflozin Reverses Cardiac Fibrosis in Diabetic HFpEF, Study Finds

Dapagliflozin reverses myocardial fibrosis in HFpEF with diabetes, suggesting a disease-modifying effect.

Does Magnesium Aid Glycaemic Control in Type 2 Diabetes?

Understand how magnesium supplementation modestly improves fasting glucose in Type 2 diabetes.

New Urinary Biomarkers Linked to Slower Progression of Diabetic Kidney Disease

Learn how EGF and UMOD levels may predict diabetic kidney disease progression, offering new tools for clinical risk assessment.

Vitamin D Supplementation May Improve Blood Sugar in Type 2 Diabetes

Discover how low-dose vitamin D may help regulate blood sugar in people with Type 2 diabetes.

Loading posts...

« Previous 1 … 5 6 7 8 9 … 41 Next »